Radu Tănăsescu

4.5k total citations
100 papers, 3.1k citations indexed

About

Radu Tănăsescu is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Radu Tănăsescu has authored 100 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pathology and Forensic Medicine, 20 papers in Immunology and 17 papers in Neurology. Recurrent topics in Radu Tănăsescu's work include Multiple Sclerosis Research Studies (33 papers), Systemic Lupus Erythematosus Research (13 papers) and Peripheral Neuropathies and Disorders (9 papers). Radu Tănăsescu is often cited by papers focused on Multiple Sclerosis Research Studies (33 papers), Systemic Lupus Erythematosus Research (13 papers) and Peripheral Neuropathies and Disorders (9 papers). Radu Tănăsescu collaborates with scholars based in United Kingdom, Romania and United States. Radu Tănăsescu's co-authors include Cris S. Constantinescu, Maurizio Leone, Matti Hillbom, Geir Bråthen, Christopher R. Tench, Bruno Gran, Andrei Ivashynka, R. Galvin, Manole Cojocaru and Inimioara Mihaela Cojocaru and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Radu Tănăsescu

95 papers receiving 3.0k citations

Peers

Countries citing papers authored by Radu Tănăsescu

Since Specialization

Citations

This map shows the geographic impact of Radu Tănăsescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radu Tănăsescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radu Tănăsescu more than expected).

Fields of papers citing papers by Radu Tănăsescu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radu Tănăsescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radu Tănăsescu. The network helps show where Radu Tănăsescu may publish in the future.

Co-authorship network of co-authors of Radu Tănăsescu

This figure shows the co-authorship network connecting the top 25 collaborators of Radu Tănăsescu. A scholar is included among the top collaborators of Radu Tănăsescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radu Tănăsescu. Radu Tănăsescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectories 2025 ·Journal of the Neurological Sciences ·Carolyn Young, David Rog, Basil Sharrack, Suresh Kumar Chhetri, Seema Kalra, Timothy Harrower, (unknown), John Thorpe, Richard Nicholas, Helen Ford, Gavin McDonnell, Alan Tennant, Roger Mills, Radu Tănăsescu	2
2	Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients 2024 ·Multiple Sclerosis and Related Disorders ·Rachael Tarlinton, Radu Tănăsescu, Claire Shannon‐Lowe, Bruno Gran	0
3	Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells 2023 ·Neurology and Therapy ·Radu Tănăsescu, Nanci Frakich, I‐Jun Chou, Perla Filippini, (unknown), (unknown), Ranjithmenon Muraleedharan, (unknown), David Onion, Cris S. Constantinescu	6
4	Brain connectivity-guided, Optimised theta burst transcranial magnetic stimulation to improve Central Pain Modulation in knee Osteoarthritis Pain (BoostCPM): protocol of a pilot randomised clinical trial in a secondary care setting in the UK 2023 ·BMJ Open ·(unknown), Duncan J. Hodkinson, (unknown), (unknown), Stefan Pszczółkowski, Christopher R. Tench, Radu Tănăsescu, Sudheer Lankappa, Richard Morriss, David A. Walsh, Dorothee P. Auer	3
5	Multiple Sclerosis vision questionnaire (MSVQ-7): Reliability, validity, precision and discrimination 2023 ·Multiple Sclerosis and Related Disorders ·Carolyn Young, David Rog, Radu Tănăsescu, Seema Kalra, Dawn Langdon, Alan Tennant, Roger Mills	2
6	The Potential for EBV Vaccines to Prevent Multiple Sclerosis 2022 ·Frontiers in Neurology ·P.A.C. Maple, Alberto Ascherio, Jeffrey I. Cohen, Gary Cutter, Gavin Giovannoni, Claire Shannon‐Lowe, Radu Tănăsescu, Bruno Gran	20
7	Increased IL-2 and Reduced TGF-β Upon T-Cell Stimulation are Associated with GM-CSF Upregulation in Multiple Immune Cell Types in Multiple Sclerosis 2020 ·Biomedicines ·Jehan Aram, Nanci Frakich, Elena Morandi, Mohammed Alrouji, Amal Samaraweera, David Onion, Ian Spendlove, Sergio L. Colombo, Radu Tănăsescu, Bruno Gran, Cris S. Constantinescu	7
8	Primary versus Secondary Central Nervous System Melanoma: a Diagnostic Dilemma and Report of a Case 2019 ·SHILAP Revista de lepidopterología ·(unknown), Laura Dumitrescu, (unknown), (unknown), (unknown), (unknown), Radu Tănăsescu, Bogdan Ovidiu Popescu	1
9	Reduced Myelin Signal in Normal-appearing White Matter in Neuromyelitis Optica Measured by 7T Magnetic Resonance Imaging 2019 ·Scientific Reports ·I‐Jun Chou, Radu Tănăsescu, Olivier Mougin, Penny Gowland, Christopher R. Tench, William Whitehouse, Bruno Gran, Esmaeil Nikfekr, Basil Sharrack, Gordon Mazibrada, Cris S. Constantinescu	17
10	Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis 2018 ·Neurology and Therapy ·Jehan Aram, (unknown), Radu Tănăsescu, Cris S. Constantinescu	17
11	The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis 2017 ·PLoS ONE ·Elena Morandi, Radu Tănăsescu, Rachael Tarlinton, Cris S. Constantinescu, Weiya Zhang, Christopher R. Tench, Bruno Gran	84
12	The future of multiple sclerosis treatments 2016 ·Expert Review of Neurotherapeutics ·(unknown), Cris S. Constantinescu, Radu Tănăsescu	6
13	Innate immune regulation of autoimmunity in multiple sclerosis: Focus on the role of Toll-like receptor 2 2016 ·Journal of Neuroimmunology ·Md Jakir Hossain, Radu Tănăsescu, Bruno Gran	30
14	Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis 2014 ·Expert Opinion on Drug Metabolism & Toxicology ·Radu Tănăsescu, Cris S. Constantinescu	14
15	Coordinate Based Meta-Analysis of Functional Neuroimaging Data Using Activation Likelihood Estimation; Full Width Half Max and Group Comparisons 2014 ·PLoS ONE ·Christopher R. Tench, Radu Tănăsescu, Dorothee P. Auer, William J. Cottam, Cris S. Constantinescu	15
16	Helminth Therapy for MS 2014 ·Current topics in behavioral neurosciences ·Radu Tănăsescu, Cris S. Constantinescu	11
17	The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease 2012 ·Amino Acids ·Radu Tănăsescu, Bruno Gran, Cris S. Constantinescu	13
18	Update on Wernicke’s: considerations on epidemiology (II) 2011 ·SHILAP Revista de lepidopterología ·(unknown), Laura Dumitrescu, (unknown), (unknown), (unknown), Marina Ticmeanu, Radu Tănăsescu, (unknown)	1
19	Cannabinoids and the immune system: An overview 2010 ·Immunobiology ·Radu Tănăsescu, Cris S. Constantinescu	185
20	RECURRENT MYELITIS AND SICCA SYNDROME: A TIME-REVEALED ASSOCIATION 2008 ·SHILAP Revista de lepidopterología ·Radu Tănăsescu, (unknown), Marina Ticmeanu, (unknown), (unknown), (unknown), Adriana Hristea, Cristian Băicuş	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact